Atrophic Scar Clinical Trial
Official title:
The Efficacy of Subcision in Combination With PRP Injection and Fractional Co2 Laser in Treatment of Atrophic Scar: Clinical and Ultrasonic Study
Verified date | March 2024 |
Source | Assiut University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
There are more than 100 million patients who develop scar formation caused by various factors, such as post-inflammatory acne and trauma (1). They often have physical, aesthetic, psychological, and social barriers. Scar tissue is naturally a stage of wound healing. Abnormal wound healing produces a spectrum of scar tissue types such as atrophic, hypertrophic, and keloid scars (2). Atrophic scars are dermal depressions, which are commonly caused by the destruction of collagen following inflammatory process. This permanent disfiguring sequelae correlates with the duration of pathology, severity of lesion, and delay in therapy (3). Treatment of atrophic acne scars remains a therapeutic challenge, yet there is no standard option as the most effective treatment (4). A range of possible options has been investigated including surgical techniques (subcision, non-ablative laser treatment, resurfacing techniques (ablative laser treatment, dermabrasion), and injection or dermal fillers or fat, and a combination of two or more modalities (5). Ultrasound is a unique non-invasive and non-radiating medical imaging tool in the investigation of dermatological diseases by providing detailed anatomic and physiologic data of skin lesions and deeper soft tissue changes. Lesion size in three dimensions-lengths, width, and depth, morphology, the detailed anatomic information provided by sonography is useful to assessment of effect of different types of treatment modality to improve atrophic scar and avoid invasive assessment tools as punch biopsy for histopathological examination (6)
Status | Not yet recruiting |
Enrollment | 45 |
Est. completion date | March 15, 2027 |
Est. primary completion date | March 15, 2027 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 12 Years to 70 Years |
Eligibility | Inclusion Criteria: - Patients aged from 12 to 60 years with - post inflammatory atrophic scar. - post traumatic atrophic scar. - post operative atrophic scar Exclusion Criteria: - post acne scar. - active skin infection. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | change of dermal thickness in sonar and Vancouver scale | objective | 3 years |
Status | Clinical Trial | Phase | |
---|---|---|---|
Not yet recruiting |
NCT06435884 -
Long-Term Follow-up of Adult With Atorpphic Scars Treated With TRTP-101
|
||
Completed |
NCT06000839 -
A Safety and Effectiveness Study of CELLBOOSTER® Lift (Stabilized Booster Complex Using CHAC Technology)
|
N/A | |
Recruiting |
NCT05936437 -
Clinical Benefits and Safety of Combined Polynucleotides and Hyaluronic Acid - Newest - for Acne Scars Treatment
|
N/A | |
Active, not recruiting |
NCT04519515 -
Vollure for the Correction of Atrophic Facial Scarring
|
N/A | |
Completed |
NCT03264573 -
Role of Stem Cells, Platelet Rich Plasma in Treatment of Scars
|
N/A | |
Not yet recruiting |
NCT05695807 -
Carboxytherapy in the Treatment of Atrophic Scars
|
N/A | |
Recruiting |
NCT06210919 -
Safety and Tolerability of Autologous Adipose-derived Mesenchymal Stem Cells Therapy in Adults With Atrophic Scars
|
Phase 1 | |
Completed |
NCT05686603 -
Comparison of Picosecond Lasers vs. Ablative Fractional Er:YAG Lasers in Treating Atrophic Scar
|
N/A |